Matthew J. Matasar

Phase I dose escalation of ibrutinib and buparlisib in relapsed/refractory diffuse large B-cell lymphoma (DLBCL), mantle cell lymphoma (MCL), and follicular lymphoma (FL).

Ahmet Dogan, Andrew D. Zelenetz, Heiko Schöder, 2017 .

Expert Second Opinion Pathology Review of Lymphoma in the Era of the World Health Organization Classification.

Andrew D. Zelenetz, Weiji Shi, Matthew J. Matasar, 2007 .